RETeval™ ERG/VEP: Advancing Retinal Function Testing Across Disciplines
December 18, 2024
At APVRS 2024, we chatted with ophthalmologist Dr. Vishal Raval (LV Prasad Eye Institute) and Dan Cao (Guangdong Provincial People’s Hospital) about LKC Technologies’ handheld RETeval™ ERG/EVP device, a fast and noninvasive tool for assessing retinal health. The convo highlighted the device’s application across various disciplines, including diabetic retinopathy, glaucoma, cataracts, and pediatric ophthalmology—along with its involvement in two studies.
In the session, Dr. Cao talked about RETeval’s role in her work evaluating retinal function and its ability to identify links between peripheral lesions and reduced retinal performance. Dr. Vishal Raval from LV Prasad Eye Institute also shared insights into its use for retinal toxicity assessments and its adaptability to a range of conditions, including retinoblastoma.
Learn more about the RETeval and its applications at www.lkc.com.
